Daridorexant for the Treatment of Insomnia Disorder

Findings from the Phase 3 Trials

molecule4white
Return to Daridorexant Resources
This website is subject to the terms and conditions outlined in the legal and privacy statement.

Terms and Conditions | Privacy Policy 

Copyright © 2024 Idorsia Pharmaceuticals Ltd
Whilst clicking on this, you are confirming that you are an HCP outside of US. Consumer (e.g., patient) Healthcare Professional